Future studies will investigate long-term implications of FMT on host metabolism and immune function, and effects on brain ...

A key viral mechanism that allows HSV-1 to evade the brain’s natural defenses has been uncovered and tested to identify new ...

In developing this automated cell therapy processing platform, Limula’s founders aim to create a disruptive production ...

Researchers still don’t fully understand the cause of multiple sclerosis or why the rate of progression is so difficult to ...

As difficult-to-treat infections continue to rise, phage therapies are becoming important complements to existing treatments.

Findings suggest that slack titin molecules drive muscle disease, potentially through mechanisms shared with other mechanical ...

This technique could enable wearable devices to boost brain waste clearance in aging adults or patients with neurological ...

Phase I trial patients experienced shrinkage of brain tumors and extended survival rates beyond the standard prognosis of one ...

Human study findings suggest there are subtypes within prediabetes, and that subtype could determine the foods individuals ...

Sanofi to acquire Blueprint Medicines for up to $9.5B to expand its rare immunological disease portfolio, including an ...

Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...

Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...